Work

Prospects for near-infrared technology in remotely triggered drug delivery

Year: 2014

Type: editorial

Abstract: Remotely triggered drug delivery devices have recently been realized as injectable or implantable formulations that enable the patient or physician to control the timing and dose of drug release over an extended period. Such devices could increase patient compliance, maximize therapeutic effectiveness and minimize side effects. They can be triggered by near-infrared (NIR) light, which can harmlessly and painlessly pass through tissue at controlled doses and exposure times. We discuss the use of NIR-triggered devices and materials, with examples. Safety issues and future prospects are also addressed.

Source: Expert Opinion on Drug Delivery

DOI: 10.1517/17425247.2014.930435

Authors: Brian P Timko, Daniel S Kohane

Institutions: Boston Children's Hospital, Harvard University, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute of General Medical Sciences